Tech Company Financing Transactions
Luna Diabetes Funding Round
Vensana Capital, Ascensia and Winklevoss Capital participated in a $23.6 million Series A venture round for Luna Diabetes. The round was recorded on 8/25/2025.
Transaction Overview
Company Name
Announced On
8/25/2025
Transaction Type
Venture Equity
Amount
$23,600,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance regulatory submissions, conduct clinical studies, build manufacturing capacity, and expand clinical and market access programs.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
San Diego, CA Undisclosed
USA
San Diego, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Luna Diabetes, we are driven by a singular mission: to bring the transformative power of insulin automation to the masses. Luna Diabetes was founded by John Sjölund, Jon Brilliant, and Sean Saint -- three industry pioneers with firsthand experience managing diabetes, either for themselves or for their child.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Jon Brilliant
Founder
Sean Saint
Founder
John Sjölund
Browse more venture capital transactions:
Prev: 8/25/2025: Holo venture capital transaction
Next: 8/25/2025: Heritage Distilling venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs